Joel Ramin’s 12 West Capital Discloses New Passive Stake in Zulily Inc (ZU)

12 West Capital Management, managed by Joel Ramin, has disclosed, in a new filing with the Securities and Exchange Commission, adding Zulily Inc (NASDAQ:ZU) to its equity portfolio. The fund currently holds 735,804 shares of the company. The stake amasses 5.6% of the stock, and is passive by nature.

Zulily_Logo

Zulily Inc (NASDAQ:ZU) is an e-commerce company, which offers daily deals for moms, babies and kids. The company helps moms find new and unique products. The products, offered by Zulily Inc (NASDAQ:ZU), include women’s apparel, kids’ apparel and toys.

At the end of the third quarter of 2013, 12 West Capital Management owned 1.61 million shares of FleetCor Technologies Inc. (NYSE:FLT), with a reported value of about $177.76 million. The fund also held 1.15 million shares of Tripadvisor Inc. (NASDAQ:TRIP).

In November 2013, Zulily Inc (NASDAQ:ZU) conducted its initial public offering (IPO) selling 11,500,000 shares of its class A common stock at $22.00 per share. The offering included a total of 6,377,500 shares by the company and a total of 5,122,500 shares owned by certain selling stockholders.

12 West Capital Management was founded by Joel Ramin in 2011. Ramin previously worked at Roberto Mignone‘s Bridger Capital. The fund prefers to put its money in short positions, but also invests in long equity holdings.

Disclosure: none

Recommended reading:

Donald Yacktman Latest Moves Involve SYSCO Corporation (SYY)

Two Insiders and Mason Hawkins Increase Their Bets on CONSOL Energy Inc. (CNX)

Canyon Capital Advisors’ Recent Moves Include DHT Holdings Inc (DHT), Cumulus Media Inc (CMLS) & Others

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!